Wim J. E. Tissing

12.3k citations

259 papers · 6.8k indexed · 2 hit papers · h-index 43

Pediatrics, Perinatology and Child Health top 0.2%
Oncology top 1%
Public Health, Environmental and Occupational Health top 0.5%
Pulmonary and Respiratory Medicine top 1%
Molecular Biology top 10%

Co-authors: Eveline S.J.M. de Bont Rob Pieters Hermie J. M. Harmsen Michel J. van Vliet Willem A. Kamps Leontien C.M. Kremer Marry M. van den Heuvel‐Eibrink Aeltsje Brinksma
Topics: Childhood Cancer Survivors' Quality of Life (148 papers)Acute Lymphoblastic Leukemia research (74 papers)Oral health in cancer treatment (42 papers)
Cited by: Otorhinolaryngology Pediatrics, Perinatology and Child Health Oncology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
Partner nations: Netherlands United States Germany

In The Last Decade

Wim J. E. Tissing

247 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

2015 341 citations Wim J. E. Tissing, Elvira C van Dalen et al. profile →
Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines

2019 229 citations Wim J. E. Tissing et al. Supportive Care in Cancer profile →

Peers

Countries citing papers authored by Wim J. E. Tissing

Since Specialization

Citations

This map shows the geographic impact of Wim J. E. Tissing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim J. E. Tissing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim J. E. Tissing more than expected).

Fields of papers citing papers by Wim J. E. Tissing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim J. E. Tissing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim J. E. Tissing. The network helps show where Wim J. E. Tissing may publish in the future.

Co-authorship network of co-authors of Wim J. E. Tissing

This figure shows the co-authorship network connecting the top 25 collaborators of Wim J. E. Tissing. A scholar is included among the top collaborators of Wim J. E. Tissing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim J. E. Tissing. Wim J. E. Tissing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated care networks in multidisciplinary rehabilitation therapy services for childhood oncology close to home: lessons learned from an international environmental scan 2025 ·Supportive Care in Cancer ·(unknown),Jan Willem Gorter,Elvira C van Dalen,Marjolijn Ketelaar,Wim J. E. Tissing	1
2	Clinical presentation and outcome of invasive mould disease in paediatric patients with acute lymphoblastic leukaemia 2024 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Wim J. E. Tissing,Rob Pieters,Louis Bont,Roger J. M. Brüggemann,Tom F.W. Wolfs	3
3	Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature review 2023 ·Critical Reviews in Oncology/Hematology ·(unknown),(unknown),Wim J. E. Tissing,(unknown),Jill A. McKay,Ellen Kampman,Dieuwertje E. Kok	13
4	Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study 2023 ·Annals of Hematology ·Anne‐Grete Märtson,(unknown),Anette Veringa,Lei Liu,Hannah R. Wardill,(unknown),Tjip S. van der Werf,Hermie J. M. Harmsen,Marieke G. G. Sturkenboom,Lambert F. R. Span,Wim J. E. Tissing,Jan‐Willem C. Alffenaar	2
5	Thyroid Profile in the First Three Months after Starting Treatment in Children with Newly Diagnosed Cancer 2023 ·Cancers ·(unknown),Cor van den Bos,Miranda P. Dierselhuis,Marta Fiocco,A. A. Verrijn Stuart,Eef G.W.M. Lentjes,Sabine Plasschaert,Wim J. E. Tissing,Hanneke M. van Santen	2
6	Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown),Simone L. Broer,(unknown),Jos W. R. Twisk,M. van den Berg,Cornelis B. Lambalk,Flora E. van Leeuwen,A. Overbeek,Marry M. van den Heuvel‐Eibrink,Wendy van Dorp,Andrica de Vries,Jacqueline J. Loonen,Helena J. H. van der Pal,Leontien C.M. Kremer,Wim J. E. Tissing,Birgitta Versluys,Gertjan J.L. Kaspers,Eline van Dulmen‐den Broeder,Margreet A. Veening,(unknown)	3
7	Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients 2023 ·Cancers ·(unknown),(unknown),Peter M. Hoogerbrugge,Caroline A. Lindemans,Stefan Nierkens,Gaby Smits,Rob van Binnendijk,Louis Bont,Wim J. E. Tissing	7
8	Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS‐LATER study 2023 ·Cancer ·(unknown),(unknown),Ewald M. Bronkhorst,Leontien C.M. Kremer,Eline van Dulmen‐den Broeder,Margriet van der Heiden‐van der Loo,Wim J. E. Tissing,Helena J. H. van der Pal,Nicole M. A. Blijlevens,Marry M. van den Heuvel‐Eibrink,Birgitta Versluys,Dorine Bresters,Cécile M. Ronckers,Iris Walraven,C. C. M. Beerendonk,Jacqueline J. Loonen,(unknown)	1
9	Micafungin twice-a-week for prophylaxis of invasive Aspergillus infections in children with acute lymphoblastic leukaemia: A controlled cohort study 2023 ·International Journal of Antimicrobial Agents ·(unknown),Tom F.W. Wolfs,Eline W. Muilwijk,Marta Fiocco,Rob Pieters,Roger J. M. Brüggemann,Wim J. E. Tissing	6
10	Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting 2022 ·Supportive Care in Cancer ·(unknown),Evelien de Vos‐Kerkhof,Catherine F. Enters-Weijnen,Marianne D. van de Wetering,Wim J. E. Tissing,Matthijs M. Tibben,Hilde Rosing,Arief Lalmohamed,Alwin D. R. Huitema,C. Michel Zwaan	4
11	Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy 2022 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),Wim J. E. Tissing,Rob Pieters,Inge M. van der Sluis,(unknown)	1
12	Clinical Pharmacokinetics of Triazoles in Pediatric Patients 2021 ·Clinical Pharmacokinetics ·(unknown),Wim J. E. Tissing,Eline W. Muilwijk,Tom F.W. Wolfs,Roger J. M. Brüggemann	17
13	Female reproductive function after treatment of childhood acute lymphoblastic leukemia 2021 ·Pediatric Blood & Cancer ·(unknown),Marloes van Dijk,A. Overbeek,Gertjan J.L. Kaspers,Cornelis B. Lambalk,C. C. M. Beerendonk,Dorine Bresters,Margriet van der Heiden‐van der Loo,Marry van den Heuvel‐Eibrink,Leontien C.M. Kremer,Jacqueline J. Loonen,Helena van der Pal,Cécile M. Ronckers,Wim J. E. Tissing,Birgitta Versluys,Flora E. van Leeuwen,M. van den Berg,Eline van Dulmen‐den Broeder,(unknown)	5
14	Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study 2021 ·Journal of Antimicrobial Chemotherapy ·(unknown),Tom F.W. Wolfs,Rob ter Heine,Eline W. Muilwijk,Wim J. E. Tissing,Roger J. M. Brüggemann	7
15	Smell and taste function in childhood cancer patients: a feasibility study 2020 ·Supportive Care in Cancer ·Mirjam van den Brink,(unknown),(unknown),Marta Fiocco,Remco C. Havermans,Wim J. E. Tissing	14
16	High prevalence of parent‐reported sleep problems in pediatric patients with acute lymphoblastic leukemia after induction therapy 2020 ·Pediatric Blood & Cancer ·Lindsay M. H. Steur,Martha A. Grootenhuis,Eus J.W. Van Someren,Natasha K. A. van Eijkelenburg,Inge M. van der Sluis,Natasja Dors,Cor van den Bos,Wim J. E. Tissing,Gertjan J.L. Kaspers,Raphaële R. L. van Litsenburg	26
17	a Decrease in Vitamin D Levels Is Associated with Methotrexate-Induced Oral Mucositis in Children with Acute Lymphoblastic Leukemia 2017 ·Blood ·Natanja Oosterom,(unknown),Sandra G. Heil,Róbert de Jonge,Wim J. E. Tissing,Rob Pieters,Marry M. van den Heuvel‐Eibrink,Annemieke C. Heijboer,Saskia M.F. Pluijm	1
18	THE INFLUENCE OF CO-MEDICATION ON PLATINUM-RELATED OTOTOXICITY IN LONG-TERM SURVIVORS OF CHILDHOOD CANCER: AN OBSERVATIONAL DCOG STUDY 2015 ·Data Archiving and Networked Services (DANS) ·Eva Clemens,Elisabeth G.E. de Vries,(unknown),(unknown),(unknown),Wim J. E. Tissing,Jacqueline J. Loonen,Dorine Bresters,Birgitta Versluys,Sebastian Neggers,Leontien C.M. Kremer,(unknown),(unknown)	1
19	A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia 2014 ·Blood ·Wing H. Tong,Rob Pieters,Gertjan J.L. Kaspers,D. Maroeska W. M. te Loo,Marc Bierings,Cor van den Bos,Wouter J.W. Kollen,Wim C.J. Hop,Claudia Lanvers‐Kaminsky,Mary V. Relling,Wim J. E. Tissing,Inge M. van der Sluis	155
20	DO ADOLESCENTS WITH CANCER AND HEALTHY PEERS DIFFER WITH REGARD TO THE CONTENT AND ABSTRACTION LEVEL OF THEIR SELF-GENERATED PERSONAL GOALS? 2012 ·Data Archiving and Networked Services (DANS) ·Esther Sulkers,(unknown),Aeltsje Brinksma,Pétrie F. Roodbol,Willem A. Kamps,Wim J. E. Tissing,Robbert Sanderman,Joke Fleer	1

About Wim J. E. Tissing

Wim J. E. Tissing is a scholar working on Pediatrics, Perinatology and Child Health, Otorhinolaryngology and Public Health, Environmental and Occupational Health, having authored 259 papers that have together received 6.8k indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (148 papers), Acute Lymphoblastic Leukemia research (74 papers) and Oral health in cancer treatment (42 papers). The work is most often cited by research in Otorhinolaryngology (599 citations), Pediatrics, Perinatology and Child Health (2.5k citations) and Oncology (1.9k citations). Wim J. E. Tissing has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Eveline S.J.M. de Bont, Rob Pieters, Hermie J. M. Harmsen, Michel J. van Vliet, Willem A. Kamps, Leontien C.M. Kremer, Marry M. van den Heuvel‐Eibrink, Aeltsje Brinksma, Esther Sulkers and Gertjan J.L. Kaspers. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact